Response of Pulmonary Functions to Deep Breathing Exercise in Twin Pregnancy

November 18, 2023 updated by: Noha Ahmed Fouad Abd-Elrahman, Badr University
this study is to investigate the response of pulmonary function to deep breathing exercise in twin pregnancy

Study Overview

Detailed Description

Physiological changes during pregnancy impose numerous changes on the respiratory system that can affect the health of both mother and foetus. Regarding the importance of the normal breathing in the health of mother and foetus.

Many investigators have studied pulmonary function tests during normal pregnancy, most of them found a significant decrease in pulmonary function test parameters during all pregnancy trimesters. Others showed that the PFTs parameters are normal in the first trimester but there was significant decrease in them in the second and third trimesters, or in the third trimester only.

Study Design: Randomized control trial Sixty twin pregnant women during the third trimester i (27th weeks gestation),aged 25 to 35 years old and body mass index was ≥ 30 kg/m², will participate in this study. They will be assigned into two equal groups; control group and study group ( study group only will make deep breathing exercise inform of diaphragmatic and costal breathing 3times a day for 15 repetitions each exercise for 9 weeks, pulmonary function test will be applied for both groups at 27th week gestation and at 36th weeks gestation.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Giza, Egypt
        • Soaad kafafy university hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • All pregnant women will be in 27th week gestation
  • They will be recruited from Soaad kafafy university hospital
  • Their age between 25-35 years old
  • Their BMI ≥30Kg/m2

Exclusion Criteria:

  • Pregnant women with any pulmonary disorders before pregnancy
  • Women suffering from any physical or mental disorders.
  • Pregnant women with gestational diabetes
  • Pregnant women with gestational hypertension
  • Pregnant women with asthma

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: study group
30 women with twin pregnancy during the third trimester at 27th weeks gestation will make deep breathing exercise inform of diaphragmatic and costal breathing 3times a day for 15 repetitions each exercise for 9 weeks, pulmonary function test will be applied at 27th week gestation and at 36th weeks gestation.
deep breathing exercise inform of diaphragmatic and costal breathing 3times a day for 15 repetitions each exercise for 9 weeks,
No Intervention: control group
30 women with twin pregnancy during the third trimester at 27th weeks gestation will not receive any special treatment and will be assessed with pulmonary function test at 27th week gestation and at 36th weeks gestation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
forced vital capacity (FVC)
Time Frame: FVC will be applied at 27th week gestation and at 36th weeks gestation (3 months)
inspiratory reserve volume + tidal volume+ expiratory reserve volume
FVC will be applied at 27th week gestation and at 36th weeks gestation (3 months)
Forced Expiratory Volume in 1 Sec (FEV1)
Time Frame: FEV1 will be applied at 27th week gestation and at 36th weeks gestation (3 months)
Pulmonary Function Tests: (Forced Expiratory Volume in 1 Sec)
FEV1 will be applied at 27th week gestation and at 36th weeks gestation (3 months)
FEV1/FVC
Time Frame: FEV1/FVC will be applied at 27th week gestation and at 36th weeks gestation (3 months)
ratio between Forced Expiratory Volume in 1 Sec (FEV1) and forced vital capacity (FVC)
FEV1/FVC will be applied at 27th week gestation and at 36th weeks gestation (3 months)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Chair: Radwa S Mahmoud, PhD, Ass. Prof. Dept of PT for pediatrics, Faculty of PT, Cairo University and BUC
  • Study Chair: Shimaa HA roshdy, PhD, Lecturer of PT Dept of PT for cardiopulmonary and geriatric, Faculty of PT, MUST
  • Study Chair: Ayman A Elsallamy, PhD, Lecturer of obstetrics and gynecology, Ob/ GYN dept MUST
  • Study Chair: Doaa S Mohamed El-sayed, PhD, Lecturer of PT, Dept. of PT for women's health, Faculty of PT, BUC
  • Study Chair: Mina AG Elias, PhD, Lecturer of PT, Dept. of PT for internal medicine and geriatric, Faculty of PT, BUC
  • Principal Investigator: Noha A Fouad, PhD, Lecturer of PT, Dept. of PT for women's health, Faculty of PT, BUC

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2022

Primary Completion (Actual)

May 30, 2023

Study Completion (Actual)

June 5, 2023

Study Registration Dates

First Submitted

September 3, 2023

First Submitted That Met QC Criteria

September 3, 2023

First Posted (Actual)

September 11, 2023

Study Record Updates

Last Update Posted (Estimated)

November 22, 2023

Last Update Submitted That Met QC Criteria

November 18, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • P.T.REC/012/004052

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe